16.2 C
New York
Monday, September 25, 2023

Centessa Pharmaceuticals: A Diversified Bet In Underserved Markets (NASDAQ: CNTA)

Shot of a young businesswoman sleeping at her desk while working late in a modern office

PeopleImages/iStock through Getty Images


Established in October 2020, Centessa Pharmaceuticals ( NASDAQ: CNTA) is a clinical-stage company dedicated to producing transformative medications. Making use of an “asset-centric” technique, the business got 11 pre-revenue biotech companies in January 2021 and went public in June 2021. It has

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles